AMARIN CORP PLC\UK
جودة البيانات: 100%
AMRN
Nasdaq
Manufacturing
Chemicals
KWD 14.48
▼
KWD 0.30
(-2.03%)
القيمة السوقية: 309.15 M
السعر
KWD 14.86
القيمة السوقية
309.15 M
نطاق اليوم
—
نطاق 52 أسبوعًا
—
حجم التداول
—
فتح —
متوسط 50 يوم / 200 يوم
—
متوسط 50 يوم / 200 يوم
—
Quick Summary
النقاط الرئيسية
Revenue declined -22.20% annually over 5 years
Generating 6.73 M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 15.65%
النمو
Revenue Growth (5Y)
-22.20%
أقل من متوسط القطاع (1.82%)
Revenue (1Y)-6.55%
Earnings (1Y)N/A
FCF Growth (3Y)-1.11%
الجودة
Return on Equity
-8.40%
أعلى من متوسط القطاع (-53.34%)
ROIC-8.24%
Net Margin-18.16%
Op. Margin-23.48%
الأمان
Debt / Equity
N/A
Current Ratio3.45
Interest Coverage-7167.14
التقييم
PE (TTM|2027)
-7.97 | 12.70
أقل من متوسط القطاع (-1.47)
P/B Ratio0.67
EV/EBITDAN/A
Dividend YieldN/A
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1364 نظير)
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1364 نظير)| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -8.0 | -1.5 |
| P/B | 0.7 | 1.6 |
| ROE % | -8.4 | -53.3 |
| Net Margin % | -18.2 | -41.5 |
| Rev Growth 5Y % | -22.2 | 1.8 |
| D/E | — | 0.3 |
السعر المستهدف للمحللين
2 محللين
Hold
الحالي
KWD 14.48
المستهدف
KWD 12.00
KWD 12.00
KWD 12.00
KWD 12.00
التوقعات
مكرر الربحية المستقبلي
12.38
ربحية السهم المستقبلية
KWD 1.17
نمو ربحية السهم (تقدير)
+50.0%
الإيرادات المقدّرة
176.59 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2027 |
KWD 1.17
KWD 1.17 – KWD 1.17
|
176.59 M | 1 |
| FY2026 |
KWD 0.78
KWD 0.78 – KWD 0.78
|
174.40 M | 1 |
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| 2026 Q2 |
KWD 0.17
KWD 0.17 – KWD 0.17
|
43.11 M | 1 |
| 2026 Q1 |
KWD 0.17
KWD 0.17 – KWD 0.17
|
43.77 M | 1 |
مفاجآت الأرباح
آخر 4 أرباع
| الربع | EPS المقدر | EPS الفعلي | المفاجأة |
|---|---|---|---|
| Q42025 | KWD 0.07 | KWD 0.01 | -85.7% |
| Q32025 | KWD 0.00 | KWD 0.19 | 0.0% |
| Q22025 | -KWD 0.61 | KWD 0.87 | +242.6% |
| Q12025 | -KWD 0.40 | -KWD 0.40 | 0.0% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -6.55% | Revenue Growth (3Y) | -16.57% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -22.20% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 213.65 M | Net Income (TTM) | -38.80 M |
| ROE | -8.40% | ROA | -5.83% |
| Gross Margin | 56.57% | Operating Margin | -23.48% |
| Net Margin | -18.16% | Free Cash Flow (TTM) | 6.73 M |
| ROIC | -8.24% | FCF Growth (3Y) | -1.11% |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 3.45 |
| Interest Coverage | -7167.14 | Asset Turnover | 0.32 |
| Working Capital | 446.10 M | Tangible Book Value | 444.83 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -7.97 | Forward P/E | N/A |
| P/B Ratio | 0.67 | P/S Ratio | 1.45 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 2.18% | ||
| Market Cap | 309.15 M | Enterprise Value | 186.34 M |
| Per Share | |||
| EPS (Diluted TTM) | -0.09 | Revenue / Share | 10.27 |
| FCF / Share | 0.32 | OCF / Share | 0.32 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | -17.34% |
| SBC-Adj. FCF | -10.29 M | Growth Momentum | 15.65 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 213.65 M | 228.61 M | 306.91 M | 369.19 M | 583.19 M |
| Net Income | -38.80 M | -82.18 M | -59.11 M | -105.80 M | 7.73 M |
| EPS (Diluted) | -0.09 | -0.20 | -0.15 | -0.26 | 0.02 |
| Gross Profit | 120.87 M | 81.38 M | 165.54 M | 242.48 M | 461.86 M |
| Operating Income | -50.17 M | -91.80 M | -67.59 M | -105.87 M | 10.50 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 19.81 M | 20.87 M | 22.22 M | 30.41 M | 29.31 M |
| SG&A Expenses | 115.00 M | 152.31 M | 199.94 M | 304.42 M | 408.33 M |
| D&A | — | — | — | — | — |
| Interest Expense | 7,000.0 | 7,000.0 | 8,000.0 | 15,000.0 | 129,000.0 |
| Income Tax | 2.75 M | 4.98 M | 5.44 M | 2.00 M | 3.56 M |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 670.78 M | 685.35 M | 831.68 M | 886.18 M | 1.07 B |
| Total Liabilities | 211.49 M | 199.17 M | 279.59 M | 290.85 M | 400.97 M |
| Shareholders' Equity | 459.28 M | 486.18 M | 552.10 M | 595.33 M | 667.10 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 134.66 M | 121.04 M | 199.25 M | 217.67 M | 219.45 M |
| Current Assets | 649.88 M | 595.40 M | 724.98 M | 689.10 M | 878.73 M |
| Current Liabilities | 194.46 M | 179.95 M | 259.28 M | 259.48 M | 370.68 M |
{"event":"ticker_viewed","properties":{"ticker":"AMRN","listing_kind":"stock","pathname":"/stocks/amrn","exchange":"Nasdaq","country":"US"}}